Skip to content
Menu

TherapeuticsMD, Inc. TXMD

Full chart Compare
Set alert

Price alert · TXMD

All alert types
1.81 USD 0.00 (+0.00%)

As ofNov 19, 2026, 9:40 AM EST

1.78 Day range 1.83
1.43 52-week range 2.95
YTD
+11.04%
1 year
+9.70%

TXMD free cash flow history

Free cash flow is operating cash flow minus capital expenditure outflow. It can be negative; it is not the same as earnings.

-30,000 USD

FY 2025 · Period ended

Coverage: complete. Values in USD; not inflation adjusted.

Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.

Capital expenditure here is net of asset disposals, so free cash flow can be higher than a figure that subtracts gross purchases.

Scroll the table to see all values →

Free cash flow · annual · USD
Fiscal periodPeriod endFree cash flowYoY changeYoY %
FY 20252025-12-31-30,000408,000Not meaningful
FY 20242024-12-31-438,00047,703,000Not meaningful
FY 20232023-12-31-48,141,000-44,063,000Not meaningful
FY 20222022-12-31-4,078,000138,649,000Not meaningful
FY 20212021-12-31-142,727,00016,951,000Not meaningful
FY 20202020-12-31-159,678,0008,490,000Not meaningful
FY 20192019-12-31-168,168,000-61,139,179Not meaningful
FY 20182018-12-31-107,028,821-30,811,390Not meaningful
FY 20172017-12-31-76,217,431-6,678,944Not meaningful
FY 20162016-12-31-69,538,4879,670,889Not meaningful
FY 20152015-12-31-79,209,376-33,657,418Not meaningful
FY 20142014-12-31-45,551,958-24,743,099Not meaningful
FY 20132013-12-31-20,808,859-8,005,128Not meaningful
FY 20122012-12-31-12,803,731-7,808,369Not meaningful
FY 20112011-12-31-4,995,362-2,124,227Not meaningful
FY 20102010-12-31-2,871,135Not availableNot available

Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.

Company-reported financial statements. Retrieved 2026-11-19T07:00:40.000Z. Retrieval time is not a report date.

Open full statements

Use Add to watchlist above to save this stock.